Colorimetric oligonucleotide array for genotyping of hepatitis C virus based on the 5′ non-coding region

Clinica Chimica Acta

Volumn 388, Issue 1-2, 2008, Pages 22-27

  Mao, Hongju ^a,b   Lu, Zhimeng ^c   Zhang, Honglian ^a   Liu, Kangdong ^a   Zhao, Jianlong ^a   Jin, Gendi ^c   Gu, Shimin ^d   Yang, Mengsu ^a  

^a SHANGHAI INSTITUTE OF MICROSYSTEM AND INFORMATION TECHNOLOGY   (China)

^b UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

^c SHANGHAI SECOND MEDICAL UNIVERSITY   (China)

^d Shanghai Infectious Diseases Hospital   (China)

Author keywords

Colorimetric oligonucleotide array; DNA sequencing; Genotypes subtypes; Hepatitis C virus

Indexed keywords

ARTICLE; COLORIMETRY; CONTROLLED STUDY; DIAGNOSTIC VALUE; DNA MICROARRAY; GENOTYPE; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; INTERMETHOD COMPARISON; MICROARRAY ANALYSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS DIAGNOSIS; VIRUS TYPING;

5' UNTRANSLATED REGIONS; BASE SEQUENCE; COLORIMETRY; GENES, VIRAL; GENOTYPE; HEPACIVIRUS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; SENSITIVITY AND SPECIFICITY;

HEPATITIS C VIRUS;

EID: 37249082571     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2007.09.009     Document Type: Article

References (42)

1. Ohkoshi S., Kojima H., Tawaraya H., et al. Prevalence of antibody against non-A, non-B hepatitis virus in Japanese patients with hepatocellular carcinoma. Cancer Sci. 81 (1990) 550-553
2. Saito I., Miyamura T., Ohbayashi A., et al. Hepatitis C virus infection is associated with the development of hepatocellular carcinoma, Proc. Natl. Acad. Sci. USA 87 (1990) 6547-6549
3. Thomas D.L. Hepatitis C epidemiology. Curr. Top. Microbiol. Immunol. 242 (2000) 25-41
4. Simmonds P., Holmes E.C., Cha T.A., et al. Classification of hepatitis C virus into six major genotypes and a series of subtypes by phylogenetic analysis of the NS-5 region. J Gen Virol 74 (1993) 2391-2399
5. Stuyver L., Arnhem W.V., Wyseur A., Hernandez F., Delaporte E., and Maertens G. Classification of hepatitis C virus based on phylogenetic analysis of the theenvelope 1 and nonstructural 5B regions and identification of the five additional subtypes. Proc. Natl. Acad. Sci. USA. 91 (1994) 10134-10138
6. Lee W.M. Therapy of hepatitis C: interferon alfa-2a trials. Hepatology 26 (1997) 89S-95S
7. Poynard T., Leroy V., Cohard M., et al. Meta-analysis of interferon randomized trials in the treatment of viral hepatitis C: effects of dose and duration. Hepatology 24 (1996) 778-779
8. Tong M.J., Reddy K.R., Lee W.M., et al. Treatment of chronic hepatitis C with consensus interferon: a multicenter, ramdomized, controlled trial. Hepatology 26 (1997) 747-754
9. Lauer G.M., and Walker B.D. Hepatitis C virus infection. N Engl J Med 345 (2001) 41-52
10. McHutchinson J.G., Gordon S.C., Schiff E.R., et al. Interferon alfa-2b alone or in combination with ribavirin as initial treatment for chronic hepatitis. N Engl J Med 339 (1998) 1485-1492
11. Arens M. Clinically relevant sequence-based genotyping of HBV, HCV, CMV and HIV. J Clin Virol 22 (2001) 11-29
12. Okamoto H., Sugiyama Y., Okada S., et al. Typing hepatitis C virus by polymerase chain reaction with type-specific primers: application to clinical surveys and tracing infectious sources. J Gen Virol 73 (1992) 673-679
13. Nakao T., Enomoto N., Takada N., Takada A., and Date T. Typing of hepatitis C virus genomes by restriction fragment length polymorphism. J Gen Virol 72 (1991) 2105-2112
14. Chan S.W., McOmish F., Holmes E.C., et al. Analysis of a new hepatitis C virus type and its phylogenetic relationship to existing variants. J Gen Virol 73 (1992) 1131-1141
15. Stuyver L., Rossau R., Wyseur A., et al. Typing of hepatitis C virus isolates and characterization of new subtypes using a line probe assay. J Gen Virol 74 (1993) 1093-1102
16. Germer J.J., Rys P.N., Thorvilson J.N., and Persing D.H. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol 37 (1999) 2625-2630
17. Holland J., Bastian I., Ratcliff R.M., et al. Hepatitis C genotyping by direct sequencing of the product from the Roche Amplicor test: methodology and application to a south Australian population. Pathology 30 (1998) 192-195
18. Davis G.L., and Lau J.Y. Factors predictive of a beneficial response to therapy of hepatitis C. Hepatology 26 (1997) 122S-127S
19. Heathcote E.J., Shiffman M.L., Cooksley W.G., et al. Peginterferon alfa-2a in patients with chronic hepatitis C and cirrhosis. N Engl J Med 343 (2000) 1673-1680
20. Martinot-Peignoux M., Marcellin P., Pouteau M., et al. Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis C. Hepatology 22 (1995) 1050-1056
21. Zeuzem S., Feinman S.V., Rasenack J., et al. Peginterferon alfa-2a in patients with chronic hepatitis C. N Engl J Med 343 (2000) 1666-1672
22. Andonov A., and Chaudhary R.K. Subtyping of hepatitis C virus isolates by a line probe assay using hybridization. J Clin Microbiol 33 (1995) 254-256
23. Matera G., Barreca G.S., Lamberti A.G., Quirino A., Focà D., and Liberto M.C. An atypical pattern of HCV INNO-LiPA subtype. J Clin Virol 25 (2002) 237-238
24. Antonishyn N.A., Ast V.M., McDonald R.R., et al. Rapid genotyping of hepatitis C virus by primer-specific extension analysis. J Clin Microbiol 43 (2005) 5158-5163
25. Thiers V., Jaffredo F., Tuveri R., Chodan N., and Bréchot C. Development of a simple restriction fragment length polymorphism (RFLP) based assay for HCV genotyping and comparative analysis with genotyping and serotyping tests. J Virol Methods 65 (1997) 9-17
26. Schroter M., Feucht H.H., Schafer P., Zollner B., and Laufs R. Serological determination of HCV subtypes 1a, 1b, 2a, 2b, 3a, and 4a by a recombinant immunoblot assay. J Clin Microbiol 37 (1999) 2576-2580
27. Prescott L.E., Berger A., Pawlotsky J.M., et al. Sequence analysis of hepatitis C virus variants producing discrepant results with two different genotyping assays. J Med Virol 53 (1997) 237-244
28. Eyster M.E., Sherman K.E., Goedert J.J., Katsoulidou A., and Hatzakis A. Prevalence and changes in hepatitis C virus genotypes among multitransfused persons with hemophilia. J Infect Dis 179 (1999) 1062-1069
29. Lau J.Y., Mizokami M., Kolberg J.A., et al. Application of six hepatitis C virus genotyping systems to sera from chronic hepatitis C patients in the United States. J Infect Dis. 171 (1995) 281-289
30. Tuveri R., Rothschild C., Pol S., et al. Hepatitis C virus genotypes in French haemophiliacs: kinetics and reappraisal of mixed infections. J Med Virol 51 (1997) 36-41
31. Booth S.A., Drebot M.A., Martin I.E., and Ng L.K. Design of oligonucleotide arrays to detect point mutations: molecular typing of antibiotic resistant strains of Neisseria gonorrhoeae and hantavirus infected deer mice. Mol Cell Probes 17 (2003) 77-84
32. Call D.R., Borucki M.K., and Loge F.J. Detection of bacterial pathogens in environmental samples using DNA microarrays. J Microbiol Methods 53 (2003) 235-243
33. Cheung V.G., Morley M., Aguilar F., Massimi A., Kucherlapati R., and Childs G. Making and reading microarrays. Nat Genet 21 (1999) 15-19
34. Du W., Marsac C., Kruschina M., Ortigao F., and Florentz C. Functionalized self-assembled monolayer on gold for detection of human mitochondrial tRNA gene mutations. Anal Biochem 322 (2003) 14-25
35. Fodde R., and Losekoot M. Mutation detection by denaturing gradient gel electrophoresis (DGGE). Hum Mutat 3 (1994) 83-94
36. Fukushima M., Kakinuma K., Hayashi H., Nagai H., Ito K., and Kawaguchi R. Detection and identification of Mycobacterium species isolates by DNA microarray. J Clin Microbiol 41 (2003) 2605-2615
37. Small J., Call D.R., Brockman F.J., Straub T.M., and Chandler D.P. Direct detection of 16S rRNA in soil extracts by using oligonucleotide microarrays. Appl Environ Microbiol 67 (2001) 4708-4716
38. Troesch A., Nguyen H., Miyada C.G., et al. Mycobacterium species identification and rifampin resistance testing with high-density DNA probe arrays. J Clin Microbiol 37 (1999) 49-55
39. Ye R.W., Wang T., Bedzyk L., and Croker K.M. Applications of DNA microarrays in microbial systems. J Microbiol Methods 47 (2001) 257-272
40. Schena M.D., Shalon R., Heller A., et al. Parallel human genome analysis: microarray-based expression monitoring of 1000 genes. Proc Natl Acad Sci USA 93 (1996) 10614-10619
41. Zhou W., Du W., Cao H., et al. Detection of gyrA and parC mutations associated with ciprofloxacin resistance in Neisseria gonorrhoeae by use of oligonucleotide biochip technology. J Clin Microbiol 42 (2004) 5819-5824
42. Germer J.J., Rys P.N., Thorvilson J.N., and Persing D.H. Determination of hepatitis C virus genotype by direct sequence analysis of products generated with the Amplicor HCV test. J Clin Microbiol 37 (1999) 2625-2630